Excellent Image Quality or Superior Dose Conformity?

In the first group of developments, we reference the introduction of morphological, functional, and molecular imaging in all the steps of oncology workflow, from treatment planning to treatment delivery phases. Treatment plans based on multimodality images and daily imageguided radiotherapy (IGRT), based on volumetric images, are both becoming routine. Advanced examples of this trend are combinations of magnetic resonance imaging (MRI) [4] as well as positron emission tomography (PET) [5] scanners with treatment devices, such as linear accelerators or radioactive sources [6]. These new solutions claim the advantage of excellent imaging of the target and OARs using morphological/functional information prior or during treatment.